ORIC Pharmaceuticals Ownership 2024 | Who Owns ORIC Pharmaceuticals Now?
Institutional Ownership
69.99%
Insider Ownership
9.55%
Retail Ownership
20.46%
Institutional Holders
81.00
ORIC Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NEXTECH INVEST LTD. | 10.27% | 11.52% | 5,285,714 | 1,000,000 | 23.33% | 72,678,568 | Mar 31, 2024 |
| FMR LLC | 9.77% | 0.00% | 5,024,600 | -1,977,508 | -28.24% | 69,088,249 | Mar 31, 2024 |
| VR ADVISER, LLC | 8.54% | 2.87% | 4,394,527 | 1,966,142 | 80.97% | 60,424,746 | Mar 31, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 8.05% | 2.40% | 4,142,855 | 2,000,000 | 93.33% | 56,964,256 | Mar 31, 2024 |
| VIKING GLOBAL INVESTORS LP | 7.77% | 0.20% | 4,000,000 | 4,000,000 | 100.00% | 55,000,000 | Mar 31, 2024 |
| ALKEON CAPITAL MANAGEMENT LLC | 7.20% | 0.09% | 3,704,096 | 100,000 | 2.77% | 50,931,321 | Mar 31, 2024 |
| COLUMN GROUP LLC | 6.88% | 30.33% | 3,540,777 | -27,404 | -0.77% | 48,685,684 | Mar 31, 2024 |
| ECOR1 CAPITAL, LLC | 6.64% | 1.19% | 3,418,068 | - | - | 46,998,435 | Mar 31, 2024 |
| BLACKROCK INC. | 6.18% | 0.00% | 3,178,185 | 82,537 | 2.67% | 43,700,045 | Mar 31, 2024 |
| VANGUARD GROUP INC | 5.60% | 0.00% | 2,882,055 | 629,536 | 27.95% | 39,628,257 | Mar 31, 2024 |
| COMMODORE CAPITAL LP | 3.89% | 1.84% | 2,000,000 | 2,000,000 | 100.00% | 27,500,000 | Mar 31, 2024 |
| BOXER CAPITAL, LLC | 3.37% | 1.18% | 1,732,571 | - | - | 23,822,851 | Mar 31, 2024 |
| STATE STREET CORP | 3.34% | 0.00% | 1,716,081 | 923,007 | 116.38% | 23,596,114 | Mar 31, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3.05% | 0.00% | 1,566,736 | 915,175 | 140.46% | 21,543,000 | Mar 31, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | 2.94% | 0.23% | 1,510,861 | -222,958 | -12.86% | 20,774,339 | Mar 31, 2024 |
| NEA MANAGEMENT COMPANY, LLC | 2.92% | 1.28% | 1,500,000 | 1,500,000 | 100.00% | 20,625,000 | Mar 31, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2.16% | 4.25% | 1,113,007 | -56,993 | -4.87% | 15,303,846 | Mar 31, 2024 |
| FIRST TURN MANAGEMENT, LLC | 2.13% | 2.26% | 1,097,571 | 1,097,571 | 100.00% | 15,091,601 | Mar 31, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.00% | 0.03% | 1,030,400 | 1,030,400 | 100.00% | 14,168,000 | Mar 31, 2024 |
| INVUS FINANCIAL ADVISORS, LLC | 1.96% | 11.01% | 1,007,575 | - | - | 13,854,156 | Mar 31, 2024 |
ORIC Pharmaceuticals's largest institutional shareholder is NEXTECH INVEST LTD., holding 10.27% of the company's total share outstanding, currently valued at $72.68M. The top 10 institutional shareholders own together 76.91% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| COLUMN GROUP LLC | 6.88% | 30.33% | 3,540,777 | -27,404 | -0.77% | 48,685,684 | Mar 31, 2024 |
| NEXTECH INVEST LTD. | 10.27% | 11.52% | 5,285,714 | 1,000,000 | 23.33% | 72,678,568 | Mar 31, 2024 |
| INVUS FINANCIAL ADVISORS, LLC | 1.96% | 11.01% | 1,007,575 | - | - | 13,854,156 | Mar 31, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2.16% | 4.25% | 1,113,007 | -56,993 | -4.87% | 15,303,846 | Mar 31, 2024 |
| VR ADVISER, LLC | 8.54% | 2.87% | 4,394,527 | 1,966,142 | 80.97% | 60,424,746 | Mar 31, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 8.05% | 2.40% | 4,142,855 | 2,000,000 | 93.33% | 56,964,256 | Mar 31, 2024 |
| FIRST TURN MANAGEMENT, LLC | 2.13% | 2.26% | 1,097,571 | 1,097,571 | 100.00% | 15,091,601 | Mar 31, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | 0.79% | 2.20% | 405,000 | -271,000 | -40.09% | 5,568,750 | Mar 31, 2024 |
| COMMODORE CAPITAL LP | 3.89% | 1.84% | 2,000,000 | 2,000,000 | 100.00% | 27,500,000 | Mar 31, 2024 |
| EUCLIDEAN CAPITAL LLC | 1.92% | 1.74% | 989,410 | - | - | 13,604,388 | Mar 31, 2024 |
| NEA MANAGEMENT COMPANY, LLC | 2.92% | 1.28% | 1,500,000 | 1,500,000 | 100.00% | 20,625,000 | Mar 31, 2024 |
| ECOR1 CAPITAL, LLC | 6.64% | 1.19% | 3,418,068 | - | - | 46,998,435 | Mar 31, 2024 |
| BOXER CAPITAL, LLC | 3.37% | 1.18% | 1,732,571 | - | - | 23,822,851 | Mar 31, 2024 |
| ACUTA CAPITAL PARTNERS, LLC | 0.20% | 0.93% | 103,992 | 103,992 | 100.00% | 1,429,890 | Mar 31, 2024 |
| VIVO CAPITAL, LLC | 1.65% | 0.92% | 849,681 | - | - | 11,683,114 | Mar 31, 2024 |
| MONACO ASSET MANAGEMENT SAM | 0.25% | 0.54% | 130,000 | -150,000 | -53.57% | 1,787,500 | Mar 31, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 0.82% | 0.43% | 421,000 | 421,000 | 100.00% | 5,788,750 | Mar 31, 2024 |
| RATAN CAPITAL MANAGEMENT LP | 0.08% | 0.29% | 40,000 | 40,000 | 100.00% | 550,000 | Mar 31, 2024 |
| OPTIONS SOLUTIONS, LLC | 0.07% | 0.26% | 33,451 | 33,451 | 100.00% | 459,951 | Mar 31, 2024 |
| NICHOLAS INVESTMENT PARTNERS, LP | 0.36% | 0.26% | 183,494 | 183,494 | 100.00% | 2,523,043 | Mar 31, 2024 |
The largest ORIC Pharmaceuticals shareholder by % of total assets is COLUMN GROUP LLC. The company owns 3.54M shares of ORIC Pharmaceuticals (ORIC), representing 30.33% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | 7.77% | 0.20% | 4,000,000 | 4,000,000 | 100.00% | 55,000,000 | Mar 31, 2024 |
| COMMODORE CAPITAL LP | 3.89% | 1.84% | 2,000,000 | 2,000,000 | 100.00% | 27,500,000 | Mar 31, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 8.05% | 2.40% | 4,142,855 | 2,000,000 | 93.33% | 56,964,256 | Mar 31, 2024 |
| VR ADVISER, LLC | 8.54% | 2.87% | 4,394,527 | 1,966,142 | 80.97% | 60,424,746 | Mar 31, 2024 |
| NEA MANAGEMENT COMPANY, LLC | 2.92% | 1.28% | 1,500,000 | 1,500,000 | 100.00% | 20,625,000 | Mar 31, 2024 |
| FIRST TURN MANAGEMENT, LLC | 2.13% | 2.26% | 1,097,571 | 1,097,571 | 100.00% | 15,091,601 | Mar 31, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.00% | 0.03% | 1,030,400 | 1,030,400 | 100.00% | 14,168,000 | Mar 31, 2024 |
| NEXTECH INVEST LTD. | 10.27% | 11.52% | 5,285,714 | 1,000,000 | 23.33% | 72,678,568 | Mar 31, 2024 |
| STATE STREET CORP | 3.34% | 0.00% | 1,716,081 | 923,007 | 116.38% | 23,596,114 | Mar 31, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3.05% | 0.00% | 1,566,736 | 915,175 | 140.46% | 21,543,000 | Mar 31, 2024 |
| VANGUARD GROUP INC | 5.60% | 0.00% | 2,882,055 | 629,536 | 27.95% | 39,628,257 | Mar 31, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 0.82% | 0.43% | 421,000 | 421,000 | 100.00% | 5,788,750 | Mar 31, 2024 |
| FRED ALGER MANAGEMENT, LLC | 0.43% | 0.01% | 219,943 | 219,943 | 100.00% | 3,024,216 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.39% | 0.00% | 199,800 | 199,800 | 100.00% | 2,747,250 | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.38% | 0.00% | 196,852 | 196,852 | 100.00% | 2,706,715 | Mar 31, 2024 |
| NICHOLAS INVESTMENT PARTNERS, LP | 0.36% | 0.26% | 183,494 | 183,494 | 100.00% | 2,523,043 | Mar 31, 2024 |
| WALLEYE CAPITAL LLC | 0.29% | 0.00% | 149,337 | 149,337 | 100.00% | 2,053,384 | Mar 31, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.31% | 0.00% | 160,802 | 136,126 | 551.65% | 2,211,028 | Mar 31, 2024 |
| TD ASSET MANAGEMENT INC | 0.41% | 0.00% | 208,600 | 127,800 | 158.17% | 2,868,250 | Mar 31, 2024 |
| CITIGROUP INC | 0.26% | 0.00% | 133,906 | 127,343 | 1940.32% | 1,841,208 | Mar 31, 2024 |
As of Mar 31 2024, ORIC Pharmaceuticals's largest institutional buyer is VIKING GLOBAL INVESTORS LP. The company purchased 4.00M stocks of ORIC, valued at $55.00M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FMR LLC | 9.77% | 0.00% | 5,024,600 | -1,977,508 | -28.24% | 69,088,249 | Mar 31, 2024 |
| PROSIGHT MANAGEMENT, LP | - | - | - | -1,578,263 | -100.00% | - | Mar 31, 2024 |
| JANUS HENDERSON GROUP PLC | - | - | - | -659,054 | -100.00% | - | Mar 31, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -521,142 | -100.00% | - | Mar 31, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | 0.79% | 2.20% | 405,000 | -271,000 | -40.09% | 5,568,750 | Mar 31, 2024 |
| ORBIMED ADVISORS LLC | 0.56% | 0.07% | 287,100 | -235,868 | -45.10% | 3,947,625 | Mar 31, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | 2.94% | 0.23% | 1,510,861 | -222,958 | -12.86% | 20,774,339 | Mar 31, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -200,000 | -100.00% | - | Mar 31, 2024 |
| MORGAN STANLEY | 0.58% | 0.00% | 300,823 | -179,508 | -37.37% | 4,136,318 | Mar 31, 2024 |
| UBS OCONNOR LLC | 0.18% | 0.09% | 92,366 | -170,590 | -64.87% | 1,270,032 | Mar 31, 2024 |
| MONACO ASSET MANAGEMENT SAM | 0.25% | 0.54% | 130,000 | -150,000 | -53.57% | 1,787,500 | Mar 31, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | - | - | - | -126,800 | -100.00% | - | Mar 31, 2024 |
| D. E. SHAW & CO., INC. | - | - | - | -98,433 | -100.00% | - | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.22% | 0.00% | 110,900 | -77,600 | -41.17% | 1,525,000 | Mar 31, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | - | - | - | -72,797 | -100.00% | - | Mar 31, 2024 |
| CAPTION MANAGEMENT, LLC | 0.06% | 0.01% | 31,900 | -63,360 | -66.51% | 438,625 | Mar 31, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2.16% | 4.25% | 1,113,007 | -56,993 | -4.87% | 15,303,846 | Mar 31, 2024 |
| VICTORY CAPITAL MANAGEMENT INC | 0.17% | 0.00% | 88,540 | -37,490 | -29.75% | 1,217,425 | Mar 31, 2024 |
| JANE STREET GROUP, LLC | - | - | - | -35,274 | -100.00% | - | Mar 31, 2024 |
| COLUMN GROUP LLC | 6.88% | 30.33% | 3,540,777 | -27,404 | -0.77% | 48,685,684 | Mar 31, 2024 |
As of Mar 31 2024, ORIC Pharmaceuticals's biggest institutional seller is FMR LLC. The company sold -1.98M shares of ORIC, valued at $69.09M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | 7.77% | 0.20% | 4,000,000 | 4,000,000 | 100.00% | 55,000,000 | Mar 31, 2024 |
| COMMODORE CAPITAL LP | 3.89% | 1.84% | 2,000,000 | 2,000,000 | 100.00% | 27,500,000 | Mar 31, 2024 |
| NEA MANAGEMENT COMPANY, LLC | 2.92% | 1.28% | 1,500,000 | 1,500,000 | 100.00% | 20,625,000 | Mar 31, 2024 |
| FIRST TURN MANAGEMENT, LLC | 2.13% | 2.26% | 1,097,571 | 1,097,571 | 100.00% | 15,091,601 | Mar 31, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.00% | 0.03% | 1,030,400 | 1,030,400 | 100.00% | 14,168,000 | Mar 31, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 0.82% | 0.43% | 421,000 | 421,000 | 100.00% | 5,788,750 | Mar 31, 2024 |
| FRED ALGER MANAGEMENT, LLC | 0.43% | 0.01% | 219,943 | 219,943 | 100.00% | 3,024,216 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.39% | 0.00% | 199,800 | 199,800 | 100.00% | 2,747,250 | Mar 31, 2024 |
| NICHOLAS INVESTMENT PARTNERS, LP | 0.36% | 0.26% | 183,494 | 183,494 | 100.00% | 2,523,043 | Mar 31, 2024 |
| WALLEYE CAPITAL LLC | 0.29% | 0.00% | 149,337 | 149,337 | 100.00% | 2,053,384 | Mar 31, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.22% | 0.01% | 111,146 | 111,146 | 100.00% | 1,528,258 | Mar 31, 2024 |
| ACUTA CAPITAL PARTNERS, LLC | 0.20% | 0.93% | 103,992 | 103,992 | 100.00% | 1,429,890 | Mar 31, 2024 |
| UBS OCONNOR LLC | 0.16% | 0.00% | 80,000 | 80,000 | 100.00% | 50,000 | Mar 31, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.10% | 0.00% | 53,043 | 53,043 | 100.00% | 729,341 | Mar 31, 2024 |
| RATAN CAPITAL MANAGEMENT LP | 0.08% | 0.29% | 40,000 | 40,000 | 100.00% | 550,000 | Mar 31, 2024 |
| OPTIONS SOLUTIONS, LLC | 0.07% | 0.26% | 33,451 | 33,451 | 100.00% | 459,951 | Mar 31, 2024 |
| TUDOR INVESTMENT CORP ET AL | 0.06% | 0.00% | 29,205 | 29,205 | 100.00% | 401,569 | Mar 31, 2024 |
| LEGATO CAPITAL MANAGEMENT LLC | 0.04% | 0.04% | 23,100 | 23,100 | 100.00% | 317,625 | Mar 31, 2024 |
| NOMURA HOLDINGS INC | 0.04% | 0.00% | 20,512 | 20,512 | 100.00% | 282,040 | Mar 31, 2024 |
| PROFUND ADVISORS LLC | 0.03% | 0.01% | 17,686 | 17,686 | 100.00% | 243,183 | Mar 31, 2024 |
| CLEAR HARBOR ASSET MANAGEMENT, LLC | 0.03% | 0.02% | 13,744 | 13,744 | 100.00% | 188,980 | Mar 31, 2024 |
| PROSHARE ADVISORS LLC | 0.02% | 0.00% | 11,733 | 11,733 | 100.00% | 161,329 | Mar 31, 2024 |
| OXFORD ASSET MANAGEMENT LLP | 0.02% | 0.20% | 11,689 | 11,689 | 100.00% | 160,724 | Mar 31, 2024 |
| CITADEL ADVISORS LLC | 0.01% | - | 7,700 | 7,700 | 100.00% | 105,875 | Mar 31, 2024 |
| QUANTBOT TECHNOLOGIES LP | 0.01% | 0.00% | 5,700 | 5,700 | 100.00% | 78,375 | Mar 31, 2024 |
| QUEST PARTNERS LLC | 0.01% | 0.01% | 2,938 | 2,938 | 100.00% | 40,398 | Mar 31, 2024 |
| ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 0.00% | 0.00% | 1,964 | 1,964 | 100.00% | 27,005 | Mar 31, 2024 |
| PACER ADVISORS, INC. | 0.00% | - | 516 | 516 | 100.00% | 7,095 | Mar 31, 2024 |
| DAIWA SECURITIES GROUP INC. | 0.00% | - | 249 | 249 | 100.00% | 3,000 | Mar 31, 2024 |
| NISA INVESTMENT ADVISORS, LLC | 0.00% | - | 34 | 34 | 100.00% | 468,000 | Mar 31, 2024 |
| GAMMA INVESTING LLC | 0.00% | 0.00% | 30 | 30 | 100.00% | 413 | Mar 31, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | 8 | 8 | 100.00% | 110 | Mar 31, 2024 |
ORIC Pharmaceuticals's largest new institutional shareholder by number of shares is VIKING GLOBAL INVESTORS LP, purchased 4.00M shares, valued at $55.00M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PROSIGHT MANAGEMENT, LP | - | - | - | -1,578,263 | -100.00% | - | Mar 31, 2024 |
| JANUS HENDERSON GROUP PLC | - | - | - | -659,054 | -100.00% | - | Mar 31, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -521,142 | -100.00% | - | Mar 31, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -200,000 | -100.00% | - | Mar 31, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | - | - | - | -126,800 | -100.00% | - | Mar 31, 2024 |
| D. E. SHAW & CO., INC. | - | - | - | -98,433 | -100.00% | - | Mar 31, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | - | - | - | -72,797 | -100.00% | - | Mar 31, 2024 |
| JANE STREET GROUP, LLC | - | - | - | -35,274 | -100.00% | - | Mar 31, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -24,515 | -100.00% | - | Mar 31, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | - | - | - | -22,500 | -100.00% | - | Mar 31, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | - | - | - | -22,043 | -100.00% | - | Mar 31, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | - | - | - | -11,310 | -100.00% | - | Mar 31, 2024 |
| AJOVISTA, LLC | - | - | - | -4,357 | -100.00% | - | Mar 31, 2024 |
| COMERICA BANK | - | - | - | -1,332 | -100.00% | - | Mar 31, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -163 | -100.00% | - | Mar 31, 2024 |
ORIC Pharmaceuticals's largest sold out institutional shareholder by shares sold is PROSIGHT MANAGEMENT, LP, sold -1.58M shares, valued at -, as of undefined.
ORIC Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| CORNERCAP GROUP OF FUNDS /VA/ | 0.48% | 34,870 | 18,840 | 117.53% | Sep 30, 2022 |
| MERIDIAN FUND INC | 0.24% | 841,937 | - | - | Dec 29, 2023 |
| Advantage Advisers Xanthus Fund, L.L.C. | 0.18% | 531,690 | 8,707 | 1.66% | Mar 31, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.17% | 344,041 | - | - | Feb 29, 2024 |
| ACAP Strategic Fund | 0.13% | 1,761,863 | 54,017 | 3.16% | Dec 31, 2023 |
| PRUDENTIAL JENNISON BLEND FUND, INC. | 0.11% | 70,946 | - | - | Feb 29, 2024 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.08% | 39,270 | - | - | Dec 31, 2023 |
| ALLSPRING VARIABLE TRUST | 0.07% | 40,140 | - | - | Dec 31, 2023 |
| Voya VARIABLE PRODUCTS TRUST | 0.07% | 22,193 | - | - | Dec 31, 2023 |
| FIDELITY ADVISOR SERIES VII | 0.07% | 581,716 | -405,000 | -41.05% | Jan 31, 2024 |
| BlackRock Health Sciences Trust II | 0.07% | 185,615 | - | - | Dec 31, 2023 |
| VANGUARD VALLEY FORGE FUNDS | 0.05% | 24,507 | - | - | Dec 31, 2023 |
| CYPRESS CREEK PRIVATE STRATEGIES MASTER FUND L P | 0.04% | 93,497 | - | - | Dec 31, 2023 |
| FIDELITY MT VERNON STREET TRUST | 0.04% | 1,111,284 | -37,408 | -3.26% | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.03% | 80,000 | - | - | Dec 31, 2023 |
| PRUDENTIAL JENNISON SMALL CO FUND, INC. | 0.03% | 128,265 | - | - | Dec 29, 2023 |
| FIDELITY SECURITIES FUND | 0.02% | 1,931,053 | 304,114 | 18.69% | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 6,049 | - | - | Dec 31, 2023 |
| Fidelity Commonwealth Trust II | 0.01% | 74,952 | -13,250 | -15.02% | Aug 31, 2023 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 72,662 | 6,544 | 9.90% | Dec 31, 2023 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 34,682 | - | - | Feb 29, 2024 |
| MATTHEWS INTERNATIONAL FUNDS | 0.01% | 191,568 | - | - | Dec 31, 2023 |
| Fidelity Central Investment Portfolios LLC | 0.01% | 196,800 | - | - | Feb 29, 2024 |
| BRIDGEWAY FUNDS INC | 0.01% | 22,500 | -18,000 | -44.44% | Dec 29, 2023 |
| Voya EQUITY TRUST | 0.01% | 12,957 | - | - | Feb 29, 2024 |
| FIDELITY CAPITAL TRUST | 0.01% | 88,792 | -324,208 | -78.50% | Jan 31, 2024 |
| ETFis Series Trust I | 0.01% | 8,939 | -3,975 | -30.78% | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 2,664,159 | 311,809 | 13.26% | Dec 31, 2023 |
| FINANCIAL INVESTORS TRUST | 0.01% | 409,500 | - | - | Jan 31, 2024 |
| Humankind Benefit Corp | 0.00% | 109 | - | - | Dec 31, 2023 |
| FIDELITY COVINGTON TRUST | 0.00% | 53,936 | -9,916 | -15.53% | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 47,531 | -412 | -0.86% | Dec 31, 2023 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.00% | 53,200 | - | - | Dec 31, 2023 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 672 | - | - | Dec 31, 2023 |
| VICTORY PORTFOLIOS | 0.00% | 82,630 | 120 | 0.15% | Dec 31, 2023 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 385,682 | 28,563 | 8.00% | Feb 29, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 117,400 | - | - | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.00% | 12,700 | - | - | Dec 31, 2023 |
| Calvert Variable Products, Inc. | 0.00% | 3,223 | - | - | Dec 31, 2023 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 385,587 | 63,452 | 19.70% | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 32,768 | - | - | Dec 31, 2023 |
| AdvisorShares Trust | 0.00% | 2,513 | - | - | Dec 29, 2023 |
| SCHWAB STRATEGIC TRUST | 0.00% | 141,100 | - | - | Feb 29, 2024 |
| BlackRock ETF Trust | 0.00% | 493 | - | - | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 16,457 | 526 | 3.30% | Dec 31, 2023 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 54,859 | 15,129 | 38.08% | Feb 29, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 2,140 | - | - | Dec 31, 2023 |
| FIDELITY ADVISOR SERIES I | 0.00% | 85,899 | - | - | Feb 29, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 4,554 | - | - | Mar 31, 2024 |
| Trust for Advised Portfolios | 0.00% | 7,007 | - | - | Dec 31, 2023 |
| UBS FUNDS | 0.00% | 1,596 | - | - | Dec 31, 2023 |
| VANGUARD WORLD FUND | 0.00% | 82,429 | - | - | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 684 | - | - | Dec 31, 2023 |
| MUTUAL FUND SERIES TRUST | 0.00% | 724,972 | - | - | Dec 31, 2023 |
| Goldman Sachs ETF Trust | 0.00% | 17,938 | 17,938 | - | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 13,200 | 1,200 | 10.00% | Dec 31, 2023 |
| Dimensional ETF Trust | 0.00% | 61,373 | 55,279 | 907.11% | Jan 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 72 | - | - | Apr 30, 2021 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 2,152 | - | - | Feb 29, 2024 |
| iSHARES TRUST | 0.00% | 1,825,473 | - | - | Feb 29, 2024 |
| HC CAPITAL TRUST | 0.00% | 2,791 | - | - | Dec 31, 2023 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 171,593 | 19,032 | 12.48% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 357 | - | - | Dec 31, 2023 |
| EQ ADVISORS TRUST | 0.00% | 92,891 | 14,802 | 18.96% | Dec 31, 2023 |
| ProFunds | 0.00% | 556 | 227 | 69.00% | Jan 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 7,129 | -30 | -0.42% | Jan 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 1,500 | - | - | Dec 29, 2023 |
| ALLSPRING MASTER TRUST | 0.00% | 3,414 | - | - | Feb 29, 2024 |
| VALIC Co I | 0.00% | 14,979 | -61 | -0.41% | Feb 29, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 177 | - | - | Dec 31, 2023 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 5,876 | - | - | Dec 31, 2023 |
| PROSHARES TRUST | 0.00% | 10,750 | 5,707 | 113.17% | Feb 29, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 12,728 | 10,012 | 368.63% | Feb 29, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 188 | - | - | Feb 29, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 88,727 | 10,787 | 13.84% | Dec 31, 2023 |
| RBB FUND, INC. | 0.00% | 2,486 | - | - | Feb 29, 2024 |
| NORTHERN FUNDS | 0.00% | 23,666 | -1,070 | -4.33% | Dec 29, 2023 |
| PRUDENTIAL INVESTMENT PORTFOLIOS 2 | 0.00% | 5,216 | - | - | Jan 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 51,424 | - | - | Dec 31, 2023 |
| RYDEX VARIABLE TRUST | 0.00% | 23 | - | - | Dec 31, 2023 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,978 | 699 | 54.65% | Feb 29, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 1,641 | - | - | Dec 31, 2023 |
| ADVANCED SERIES TRUST | 0.00% | 77,240 | - | - | Dec 29, 2023 |
| SPDR SERIES TRUST | 0.00% | 699,647 | - | - | Dec 31, 2023 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 19,543 | -34,010 | -63.51% | Dec 31, 2023 |
| Franklin Alternative Strategies Funds | 0.00% | 9,045 | - | - | Feb 29, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 13,506 | -913 | -6.33% | Jan 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 4,422 | -18 | -0.41% | Jan 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 25,942 | 9,648 | 59.21% | Dec 31, 2023 |
| Brinker Capital Destinations Trust | 0.00% | 712 | - | - | Feb 29, 2024 |
| SEASONS SERIES TRUST | 0.00% | 225 | - | - | Dec 31, 2023 |
| Advisors' Inner Circle Fund III | 0.00% | 96 | 18 | 23.08% | Jan 31, 2024 |
| Goldman Sachs Trust II | 0.00% | 38,370 | - | - | Jan 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 947 | - | - | Jan 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 13,189 | - | - | Dec 31, 2023 |
| PACIFIC SELECT FUND | 0.00% | 15,958 | -577 | -3.49% | Dec 31, 2023 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 543 | - | - | Feb 29, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 2,489 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 15,609 | - | - | Dec 31, 2023 |
| WILSHIRE MUTUAL FUNDS INC | 0.00% | 530 | - | - | Dec 31, 2023 |
ORIC Pharmaceuticals's largest mutual fund holder by % of total assets is "CORNERCAP GROUP OF FUNDS /VA/", owning 34.87K shares, compromising 0.48% of its total assets.
ORIC Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 81 | -12.90% |
| 31 Dec, 23 | 93 | 4.49% |
| 30 Sep, 23 | 89 | 4.71% |
| 30 Jun, 23 | 85 | 19.72% |
| 31 Mar, 23 | 71 | 7.58% |
| 31 Dec, 22 | 66 | -10.81% |
| 30 Sep, 22 | 74 | -9.76% |
| 30 Jun, 22 | 82 | -15.46% |
| 31 Mar, 22 | 97 | 24.36% |
| 31 Dec, 21 | 78 | -2.50% |
| 30 Sep, 21 | 80 | 3.90% |
| 30 Jun, 21 | 77 | -8.33% |
| 31 Mar, 21 | 84 | 10.53% |
| 31 Dec, 20 | 76 | 40.74% |
| 30 Sep, 20 | 54 | -18.18% |
| 30 Jun, 20 | 66 | - |
As of 31 Mar 24, 81 institutions are holding ORIC Pharmaceuticals's shares, representing a decrease of -12.90% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 36,008,043 | -28.82% |
| 31 Dec, 23 | 50,584,538 | 5.32% |
| 30 Sep, 23 | 48,031,106 | 5.50% |
| 30 Jun, 23 | 45,526,901 | 38.65% |
| 31 Mar, 23 | 32,836,661 | 0.49% |
| 31 Dec, 22 | 32,676,446 | -0.02% |
| 30 Sep, 22 | 32,683,045 | -0.23% |
| 30 Jun, 22 | 32,759,819 | -3.57% |
| 31 Mar, 22 | 33,971,773 | -2.39% |
| 31 Dec, 21 | 34,805,287 | -4.36% |
| 30 Sep, 21 | 36,392,379 | 0.74% |
| 30 Jun, 21 | 36,123,589 | 1.34% |
| 31 Mar, 21 | 35,645,166 | 9.31% |
| 31 Dec, 20 | 32,607,869 | 47.20% |
| 30 Sep, 20 | 22,151,990 | 2.96% |
| 30 Jun, 20 | 21,514,508 | - |
ORIC Pharmaceuticals (ORIC) has 36.01M shares outstanding as of 31 Mar 24, down -28.82% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 69.99% | 0.90% |
| 31 Dec, 23 | 88.12% | 0.80% |
| 30 Sep, 23 | 105.21% | 1.03% |
| 30 Jun, 23 | 100.97% | 1.90% |
| 31 Mar, 23 | 72.82% | 1.07% |
| 31 Dec, 22 | 82.40% | 1.21% |
| 30 Sep, 22 | 82.58% | 1.20% |
| 30 Jun, 22 | 82.97% | 1.12% |
| 31 Mar, 22 | 86.15% | 1.02% |
| 31 Dec, 21 | 91.70% | 1.05% |
| 30 Sep, 21 | 93.29% | 0.96% |
| 30 Jun, 21 | 98.42% | 1.04% |
| 31 Mar, 21 | 97.18% | 0.44% |
| 31 Dec, 20 | 148.61% | 2.78% |
| 30 Sep, 20 | 73.07% | 0.74% |
| 30 Jun, 20 | 99.48% | - |
As of 31 Mar 24, ORIC Pharmaceuticals is held by 69.99% institutional shareholders, representing a 0.90% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 47 | -16.07% |
| 31 Dec, 23 | 56 | 36.59% |
| 30 Sep, 23 | 41 | -28.07% |
| 30 Jun, 23 | 57 | 62.86% |
| 31 Mar, 23 | 35 | 34.62% |
| 31 Dec, 22 | 26 | -18.75% |
| 30 Sep, 22 | 32 | -25.58% |
| 30 Jun, 22 | 43 | -18.87% |
| 31 Mar, 22 | 53 | 35.90% |
| 31 Dec, 21 | 39 | -9.30% |
| 30 Sep, 21 | 43 | -2.27% |
| 30 Jun, 21 | 44 | -10.20% |
| 31 Mar, 21 | 49 | -26.87% |
| 31 Dec, 20 | 67 | 168.00% |
| 30 Sep, 20 | 25 | -62.12% |
| 30 Jun, 20 | 66 | - |
47 institutional shareholders have increased their position in ORIC stock as of 31 Mar 24 compared to 56 in the previous quarter (a -16.07% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 19 | -5.00% |
| 31 Dec, 23 | 20 | -25.93% |
| 30 Sep, 23 | 27 | 50.00% |
| 30 Jun, 23 | 18 | 5.88% |
| 31 Mar, 23 | 17 | -19.05% |
| 31 Dec, 22 | 21 | -16.00% |
| 30 Sep, 22 | 25 | 13.64% |
| 30 Jun, 22 | 22 | -12.00% |
| 31 Mar, 22 | 25 | 13.64% |
| 31 Dec, 21 | 22 | 15.79% |
| 30 Sep, 21 | 19 | 11.76% |
| 30 Jun, 21 | 17 | 21.43% |
| 31 Mar, 21 | 14 | 100.00% |
| 31 Dec, 20 | 7 | -53.33% |
| 30 Sep, 20 | 15 | - |
| 30 Jun, 20 | - | - |
19 institutional shareholders have reduced their position in ORIC stock as of 31 Mar 24 compared to 20 in the previous quarter (a -5.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 81 | -12.90% | 36,008,043 | -28.82% | 69.99% | 0.90% | 47 | -16.07% | 19 | -5.00% |
| 31 Dec, 23 | 93 | 4.49% | 50,584,538 | 5.32% | 88.12% | 0.80% | 56 | 36.59% | 20 | -25.93% |
| 30 Sep, 23 | 89 | 4.71% | 48,031,106 | 5.50% | 105.21% | 1.03% | 41 | -28.07% | 27 | 50.00% |
| 30 Jun, 23 | 85 | 19.72% | 45,526,901 | 38.65% | 100.97% | 1.90% | 57 | 62.86% | 18 | 5.88% |
| 31 Mar, 23 | 71 | 7.58% | 32,836,661 | 0.49% | 72.82% | 1.07% | 35 | 34.62% | 17 | -19.05% |
| 31 Dec, 22 | 66 | -10.81% | 32,676,446 | -0.02% | 82.40% | 1.21% | 26 | -18.75% | 21 | -16.00% |
| 30 Sep, 22 | 74 | -9.76% | 32,683,045 | -0.23% | 82.58% | 1.20% | 32 | -25.58% | 25 | 13.64% |
| 30 Jun, 22 | 82 | -15.46% | 32,759,819 | -3.57% | 82.97% | 1.12% | 43 | -18.87% | 22 | -12.00% |
| 31 Mar, 22 | 97 | 24.36% | 33,971,773 | -2.39% | 86.15% | 1.02% | 53 | 35.90% | 25 | 13.64% |
| 31 Dec, 21 | 78 | -2.50% | 34,805,287 | -4.36% | 91.70% | 1.05% | 39 | -9.30% | 22 | 15.79% |
| 30 Sep, 21 | 80 | 3.90% | 36,392,379 | 0.74% | 93.29% | 0.96% | 43 | -2.27% | 19 | 11.76% |
| 30 Jun, 21 | 77 | -8.33% | 36,123,589 | 1.34% | 98.42% | 1.04% | 44 | -10.20% | 17 | 21.43% |
| 31 Mar, 21 | 84 | 10.53% | 35,645,166 | 9.31% | 97.18% | 0.44% | 49 | -26.87% | 14 | 100.00% |
| 31 Dec, 20 | 76 | 40.74% | 32,607,869 | 47.20% | 148.61% | 2.78% | 67 | 168.00% | 7 | -53.33% |
| 30 Sep, 20 | 54 | -18.18% | 22,151,990 | 2.96% | 73.07% | 0.74% | 25 | -62.12% | 15 | - |
| 30 Jun, 20 | 66 | - | 21,514,508 | - | 99.48% | - | 66 | - | - | - |
ORIC Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of ORIC Pharmaceuticals's stock was made by Chacko Jacob on Mar 08 2024, selling 40,000 shares at $16.21 per share (valued at $648.38K).
ORIC Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | 6 | 3 | 200.00% |
| Q4 2023 | 2 | 10 | 20.00% |
| Q3 2023 | - | 3 | - |
| Q2 2023 | 5 | 1 | 500.00% |
| Q1 2023 | 6 | - | - |
| Q4 2022 | 3 | 10 | 30.00% |
| Q3 2022 | 10 | 10 | 100.00% |
| Q2 2022 | 11 | - | - |
| Q1 2022 | 10 | - | - |
| Q4 2021 | 6 | 3 | 200.00% |
| Q3 2021 | 1 | 11 | 9.09% |
| Q2 2021 | 5 | 36 | 13.89% |
| Q1 2021 | 3 | 28 | 10.71% |
| Q4 2020 | - | 1 | - |
| Q2 2020 | 32 | 38 | 84.21% |
6 total buy trades, and 3 total sell trades (buy/sell ratio of 2.00%) were made by ORIC Pharmaceuticals's insiders, as of Q1 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | - | 3 | - |
| Q4 2023 | - | 3 | - |
| Q3 2023 | - | 3 | - |
| Q2 2023 | - | 1 | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | 6 | - |
| Q3 2022 | - | - | - |
| Q2 2022 | 3 | - | - |
| Q1 2022 | 4 | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | 11 | - |
| Q2 2021 | - | 36 | - |
| Q1 2021 | - | 28 | - |
| Q4 2020 | - | 1 | - |
| Q2 2020 | 2 | - | - |
As of Q1 2024, Insider owners conducted 0 open market buy trades and 3 open market sell trades of ORIC Pharmaceuticals's stocks.
ORIC Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| ANTX | AN2 Therapeutics, Inc. |
| ANEB | Anebulo Pharmaceuticals, Inc. |
| MLYS | Mineralys Therapeutics, Inc. |
| PMVP | PMV Pharmaceuticals, Inc. |
| PEPG | PepGen Inc. |
| CCCC | C4 Therapeutics, Inc. |
| IMRX | Immuneering Corporation |
| SEER | Seer, Inc. |
| DBTX | Decibel Therapeutics, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| HOWL | Werewolf Therapeutics, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| PHVS | Pharvaris N.V. |
| ELVN | Enliven Therapeutics, Inc. |
| MOLN | Molecular Partners AG |
| CELC | Celcuity Inc. |
ORIC Ownership FAQ
Who Owns ORIC Pharmaceuticals?
ORIC Pharmaceuticals is owned by institutional shareholders (69.99%), insiders (9.55%), and public (20.46%). The largest institutional shareholder of ORIC Pharmaceuticals is NEXTECH INVEST LTD. (10.27% of total shares) and the top mutual fund owner is CORNERCAP GROUP OF FUNDS /VA/ (0.48% of total shares).
Who are the major institutional shareholders of ORIC Pharmaceuticals?
ORIC Pharmaceuticals's major institutional shareholders are NEXTECH INVEST LTD., FMR LLC, VR ADVISER, LLC, FRAZIER LIFE SCIENCES MANAGEMENT, L.P., and VIKING GLOBAL INVESTORS LP. The top five shareholders own together 44.41% of the company's share outstanding.
How many ORIC Pharmaceuticals shareholders are there?
As of Mar 2024, there are 81 institutional shareholders of ORIC Pharmaceuticals.
What percentage of ORIC Pharmaceuticals is owned by NEXTECH INVEST LTD?
NEXTECH INVEST LTD owns 5.29M shares of ORIC Pharmaceuticals, representing 10.27% of the company's total shares outstanding, valued at $72.68M (as of Mar 2024).
What percentage of ORIC Pharmaceuticals is owned by FMR LLC?
As of Mar 2024, FMR LLC holds 5.02M shares of ORIC Pharmaceuticals (ORIC), compromising 9.77% of the company, valued at $69.09M.
What percentage of ORIC Pharmaceuticals is owned by VR ADVISER, LLC?
VR ADVISER, LLC is the third largest holder of ORIC Pharmaceuticals. The company owns 4.39M of the company's shares outstanding (worth $60.42M).